glp-1 migraine Drug Cuts Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and chronic migraine. Participants reported an average Suffering from Migraines? Your Doctor
Description
doi: 10.3390/microorganisms9102039 23 ColladoM
Clin Chim Acta
Notably, a seven-day regimen of intraperitoneal administration of the GLP-1 analog Exendin-4 has been observed to attenuate anxiety-like behaviors in mice undergoing heroin withdrawal
The Medicines and Healthcare products Regulatory Agency (MHRA) continues to monitor the safety profile of these medications
